The latest closing stock price for Fate Therapeutics as of November 20, 2024 is 2.22.
An investor who bought $1,000 worth of Fate Therapeutics stock at the IPO in 2013 would have $-665 today, roughly -1 times their original investment - a -9.46% compound annual growth rate over 11 years.
The all-time high Fate Therapeutics stock closing price was 117.40 on January 14, 2021.
The Fate Therapeutics 52-week high stock price is 8.83, which is 297.7% above the current share price.
The Fate Therapeutics 52-week low stock price is 1.96, which is 11.7% below the current share price.
The average Fate Therapeutics stock price for the last 52 weeks is 4.31.
An investor who bought $1,000 worth of Fate Therapeutics stock at the IPO in 2013 would have $-665 today, roughly -1 times their original investment - a -9.46% compound annual growth rate over 11 years.
The all-time high Fate Therapeutics stock closing price was 117.40 on January 14, 2021.
The Fate Therapeutics 52-week high stock price is 8.83, which is 297.7% above the current share price.
The Fate Therapeutics 52-week low stock price is 1.96, which is 11.7% below the current share price.
The average Fate Therapeutics stock price for the last 52 weeks is 4.31.